Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PolyA RNA-seq from iPSCs and differentiated iPSCs treated with Nutlin-3

ABSTRACT: PolyA RNA-seq from iPSCs and differentiated iPSCs treated with Nutlin-3

PROVIDER: PRJNA854947 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19928738_1.fastq.gz	Fastqsanger.gz
	SRR19928738_2.fastq.gz	Fastqsanger.gz
	SRR19928739_1.fastq.gz	Fastqsanger.gz
	SRR19928739_2.fastq.gz	Fastqsanger.gz
	SRR19928740_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

PolyA RNA-seq from iPSCs and differentiated iPSCs treated with Nutlin-3

Project description:Analysis of steady-state mRNA levels in induced pluripotent stem cells (iPSCs), iPSCs differentiated for 5 days with retinoic acid (RA) (5d-RAI), and iPSCs differentiated to cardiomyocytes (CM), and treated with DMSO (vehicle) or the p53 inhibitor Nutlin-3.

2022-11-08 | GSE207376 | GEO

PolyA RNA-seq from differentiated iPSCs

Project description:PolyA RNA-seq from differentiated iPSCs

| PRJNA854943 | ENA

PolyA RNA-seq from retinoic acid-differentiated iPSCs treated with GSK343, 5-aza, or Combo (GSK343 & 5-aza)

Project description:PolyA RNA-seq from retinoic acid-differentiated iPSCs treated with GSK343, 5-aza, or Combo (GSK343 & 5-aza)

| PRJNA854948 | ENA

PolyA RNA-seq from CHP212 WT and FAM193AKO cells treated with Nutlin-3

Project description:PolyA RNA-seq from CHP212 WT and FAM193AKO cells treated with Nutlin-3

| PRJNA781609 | ENA

PolyA RNA-seq from retinoic acid-differentiated iPSCs treated with GSK343, 5-aza, or Combo (GSK343 & 5-aza)

Project description:Analysis of steady-state mRNA levels in induced pluripotent stem cells (iPSCs) differentiated for 5 days with retinoic acid (RA) and treated for final 48 hrs with GSK343 (EZH2 inhibitor), 5-azacytidine (5-aza, DNA methyltransferase inhibitor), or their combination (Combo).

2022-11-08 | GSE207375 | GEO

Global gene expression analysis in macrophages treated with Nutlin-3

Project description:The goal of the study is to identify p53 target genes specific to macrophages using the p53 stabilizer, Nutlin-3. Macrophages were differentiated x-vivo from monocytes obtained from healthy volunteers either left untreated or treated for 2 hours with 100 ng/mL of lipopolysaccharide (LPS), 0.1%v/v of DMSO (vehicle control for Nutlin-3) or 10 micromolar Nutlin-3. Three replicates were included for each treatment group.

2014-05-21 | E-GEOD-43596 | biostudies-arrayexpress

Human iPSCs differentiated into SMCs

Project description:Human iPSCs were differentiated towards an induced-SMC (iSMC) phenotype in a 10-day protocol. Proteomics was performed throughout the entire differentiation time course to provide a robust, well-defined starting and ending cell population. Proteomics data verified iPSC differentiation to iSMCs. Proteomics comparison with primary human SMCs showed a high correlation with iSMCs. After iSMC differentiation, we initiated calcification in the iSMCs by culturing the cells in osteogenic media for 17 days.

2022-10-14 | PXD032353 | Pride

ATAC-seq from Nutlin-3a-treated MCF-7 cells

Project description:ATAC-seq from MCF-7 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE250017 | GEO

PolyA RNA-seq from CHP212 WT and FAM193AKO cells treated with Nutlin-3

Project description:Analysis of steady-state mRNA levels in CHP212 WT and FAM193AKO cells following DMSO or Nutlin-3a treatment.

2022-12-19 | GSE189133 | GEO

p53 binding in mouse embryonic stem cells treated with Nutlin

Project description:The goal is to profile p53 binding sites in Nutlin-treated mouse embryonic stem cells.

2021-01-31 | GSE63666 | GEO